nodes	percent_of_prediction	percent_of_DWPC	metapath
Enzalutamide—AR—Medroxyprogesterone Acetate—uterine cancer	0.254	0.302	CbGbCtD
Enzalutamide—AR—Progesterone—uterine cancer	0.168	0.2	CbGbCtD
Enzalutamide—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0555	0.0662	CbGbCtD
Enzalutamide—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0387	0.0462	CbGbCtD
Enzalutamide—CYP3A5—Progesterone—uterine cancer	0.0382	0.0456	CbGbCtD
Enzalutamide—CYP2C8—Progesterone—uterine cancer	0.0368	0.0439	CbGbCtD
Enzalutamide—CYP2C19—Progesterone—uterine cancer	0.0308	0.0368	CbGbCtD
Enzalutamide—CYP2C9—Progesterone—uterine cancer	0.0256	0.0306	CbGbCtD
Enzalutamide—ABCB1—Progesterone—uterine cancer	0.0249	0.0297	CbGbCtD
Enzalutamide—CYP2D6—Progesterone—uterine cancer	0.0234	0.028	CbGbCtD
Enzalutamide—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0225	0.0268	CbGbCtD
Enzalutamide—ABCB1—Dactinomycin—uterine cancer	0.0197	0.0235	CbGbCtD
Enzalutamide—CYP3A5—Etoposide—uterine cancer	0.0171	0.0204	CbGbCtD
Enzalutamide—CYP2C8—Etoposide—uterine cancer	0.0165	0.0196	CbGbCtD
Enzalutamide—CYP3A4—Progesterone—uterine cancer	0.0149	0.0178	CbGbCtD
Enzalutamide—CYP2B6—Doxorubicin—uterine cancer	0.0148	0.0177	CbGbCtD
Enzalutamide—ABCB1—Etoposide—uterine cancer	0.0111	0.0133	CbGbCtD
Enzalutamide—ABCB1—Doxorubicin—uterine cancer	0.0076	0.00906	CbGbCtD
Enzalutamide—CYP2D6—Doxorubicin—uterine cancer	0.00716	0.00854	CbGbCtD
Enzalutamide—CYP3A4—Etoposide—uterine cancer	0.00667	0.00796	CbGbCtD
Enzalutamide—AR—semen—uterine cancer	0.0046	0.154	CbGeAlD
Enzalutamide—CYP3A4—Doxorubicin—uterine cancer	0.00455	0.00543	CbGbCtD
Enzalutamide—AR—oviduct—uterine cancer	0.00337	0.113	CbGeAlD
Enzalutamide—Memory impairment—Progesterone—uterine cancer	0.00222	0.0207	CcSEcCtD
Enzalutamide—Disturbance in attention—Progesterone—uterine cancer	0.00201	0.0187	CcSEcCtD
Enzalutamide—Musculoskeletal pain—Progesterone—uterine cancer	0.00176	0.0164	CcSEcCtD
Enzalutamide—Musculoskeletal pain—Medroxyprogesterone Acetate—uterine cancer	0.0016	0.0149	CcSEcCtD
Enzalutamide—Injury—Progesterone—uterine cancer	0.00138	0.0128	CcSEcCtD
Enzalutamide—Sepsis—Medroxyprogesterone Acetate—uterine cancer	0.00137	0.0128	CcSEcCtD
Enzalutamide—Hot flush—Progesterone—uterine cancer	0.00135	0.0126	CcSEcCtD
Enzalutamide—Menopausal symptoms—Progesterone—uterine cancer	0.00134	0.0125	CcSEcCtD
Enzalutamide—Hot flush—Medroxyprogesterone Acetate—uterine cancer	0.00123	0.0114	CcSEcCtD
Enzalutamide—Amnesia—Medroxyprogesterone Acetate—uterine cancer	0.00122	0.0114	CcSEcCtD
Enzalutamide—Menopausal symptoms—Medroxyprogesterone Acetate—uterine cancer	0.00122	0.0113	CcSEcCtD
Enzalutamide—Infection—Carboplatin—uterine cancer	0.00118	0.0109	CcSEcCtD
Enzalutamide—Nasopharyngitis—Progesterone—uterine cancer	0.00113	0.0105	CcSEcCtD
Enzalutamide—AR—myometrium—uterine cancer	0.00108	0.0363	CbGeAlD
Enzalutamide—Sepsis—Dactinomycin—uterine cancer	0.00107	0.00995	CcSEcCtD
Enzalutamide—Bronchitis—Progesterone—uterine cancer	0.00105	0.00979	CcSEcCtD
Enzalutamide—Dry skin—Medroxyprogesterone Acetate—uterine cancer	0.00105	0.00978	CcSEcCtD
Enzalutamide—Nasopharyngitis—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00954	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Progesterone—uterine cancer	0.00102	0.00946	CcSEcCtD
Enzalutamide—Muscular weakness—Medroxyprogesterone Acetate—uterine cancer	0.00101	0.00941	CcSEcCtD
Enzalutamide—Pollakiuria—Progesterone—uterine cancer	0.00101	0.0094	CcSEcCtD
Enzalutamide—Pneumonia—Progesterone—uterine cancer	0.000981	0.00913	CcSEcCtD
Enzalutamide—Infestation NOS—Progesterone—uterine cancer	0.000975	0.00908	CcSEcCtD
Enzalutamide—Infestation—Progesterone—uterine cancer	0.000975	0.00908	CcSEcCtD
Enzalutamide—Bronchitis—Medroxyprogesterone Acetate—uterine cancer	0.000953	0.00887	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Medroxyprogesterone Acetate—uterine cancer	0.000921	0.00857	CcSEcCtD
Enzalutamide—Pollakiuria—Medroxyprogesterone Acetate—uterine cancer	0.000915	0.00852	CcSEcCtD
Enzalutamide—Sinusitis—Progesterone—uterine cancer	0.000915	0.00852	CcSEcCtD
Enzalutamide—Infestation—Medroxyprogesterone Acetate—uterine cancer	0.000884	0.00822	CcSEcCtD
Enzalutamide—Infestation NOS—Medroxyprogesterone Acetate—uterine cancer	0.000884	0.00822	CcSEcCtD
Enzalutamide—Rhinitis—Progesterone—uterine cancer	0.000878	0.00817	CcSEcCtD
Enzalutamide—Pharyngitis—Progesterone—uterine cancer	0.000869	0.00809	CcSEcCtD
Enzalutamide—Urinary tract disorder—Progesterone—uterine cancer	0.000864	0.00805	CcSEcCtD
Enzalutamide—Oedema peripheral—Progesterone—uterine cancer	0.000862	0.00803	CcSEcCtD
Enzalutamide—Connective tissue disorder—Progesterone—uterine cancer	0.00086	0.00801	CcSEcCtD
Enzalutamide—Urethral disorder—Progesterone—uterine cancer	0.000858	0.00799	CcSEcCtD
Enzalutamide—AR—epithelium—uterine cancer	0.000847	0.0285	CbGeAlD
Enzalutamide—AR—uterine cervix—uterine cancer	0.00084	0.0282	CbGeAlD
Enzalutamide—Epistaxis—Medroxyprogesterone Acetate—uterine cancer	0.000833	0.00776	CcSEcCtD
Enzalutamide—Sinusitis—Medroxyprogesterone Acetate—uterine cancer	0.000829	0.00772	CcSEcCtD
Enzalutamide—AR—smooth muscle tissue—uterine cancer	0.000817	0.0274	CbGeAlD
Enzalutamide—AR—decidua—uterine cancer	0.000801	0.0269	CbGeAlD
Enzalutamide—Angiopathy—Progesterone—uterine cancer	0.000794	0.00739	CcSEcCtD
Enzalutamide—Pharyngitis—Medroxyprogesterone Acetate—uterine cancer	0.000787	0.00733	CcSEcCtD
Enzalutamide—AR—renal system—uterine cancer	0.000786	0.0264	CbGeAlD
Enzalutamide—Urinary tract disorder—Medroxyprogesterone Acetate—uterine cancer	0.000783	0.00729	CcSEcCtD
Enzalutamide—Oedema peripheral—Medroxyprogesterone Acetate—uterine cancer	0.000781	0.00727	CcSEcCtD
Enzalutamide—Connective tissue disorder—Medroxyprogesterone Acetate—uterine cancer	0.000779	0.00726	CcSEcCtD
Enzalutamide—Urethral disorder—Medroxyprogesterone Acetate—uterine cancer	0.000777	0.00724	CcSEcCtD
Enzalutamide—Sepsis—Etoposide—uterine cancer	0.000774	0.0072	CcSEcCtD
Enzalutamide—Mental disorder—Progesterone—uterine cancer	0.000767	0.00714	CcSEcCtD
Enzalutamide—AR—endometrium—uterine cancer	0.00076	0.0255	CbGeAlD
Enzalutamide—Back pain—Progesterone—uterine cancer	0.000737	0.00686	CcSEcCtD
Enzalutamide—AR—mammalian vulva—uterine cancer	0.000735	0.0247	CbGeAlD
Enzalutamide—Neutropenia—Dactinomycin—uterine cancer	0.000723	0.00673	CcSEcCtD
Enzalutamide—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.00072	0.0067	CcSEcCtD
Enzalutamide—AR—uterus—uterine cancer	0.0007	0.0235	CbGeAlD
Enzalutamide—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.000695	0.00647	CcSEcCtD
Enzalutamide—Laryngitis—Epirubicin—uterine cancer	0.000693	0.00645	CcSEcCtD
Enzalutamide—Pneumonia—Dactinomycin—uterine cancer	0.000693	0.00645	CcSEcCtD
Enzalutamide—Vertigo—Progesterone—uterine cancer	0.000685	0.00637	CcSEcCtD
Enzalutamide—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.000668	0.00622	CcSEcCtD
Enzalutamide—Convulsion—Progesterone—uterine cancer	0.00066	0.00615	CcSEcCtD
Enzalutamide—Hypertension—Progesterone—uterine cancer	0.000658	0.00612	CcSEcCtD
Enzalutamide—Arthralgia—Progesterone—uterine cancer	0.000649	0.00604	CcSEcCtD
Enzalutamide—Anxiety—Progesterone—uterine cancer	0.000646	0.00602	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.000644	0.006	CcSEcCtD
Enzalutamide—Laryngitis—Doxorubicin—uterine cancer	0.000642	0.00597	CcSEcCtD
Enzalutamide—CYP2C8—renal system—uterine cancer	0.000636	0.0213	CbGeAlD
Enzalutamide—AR—female reproductive system—uterine cancer	0.00063	0.0211	CbGeAlD
Enzalutamide—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00062	0.00577	CcSEcCtD
Enzalutamide—Infection—Progesterone—uterine cancer	0.000618	0.00575	CcSEcCtD
Enzalutamide—CYP2C8—endometrium—uterine cancer	0.000615	0.0206	CbGeAlD
Enzalutamide—Pharyngitis—Dactinomycin—uterine cancer	0.000614	0.00572	CcSEcCtD
Enzalutamide—CYP3A5—uterine cervix—uterine cancer	0.000613	0.0206	CbGeAlD
Enzalutamide—Nervous system disorder—Progesterone—uterine cancer	0.00061	0.00568	CcSEcCtD
Enzalutamide—Skin disorder—Progesterone—uterine cancer	0.000604	0.00562	CcSEcCtD
Enzalutamide—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.000598	0.00557	CcSEcCtD
Enzalutamide—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.000588	0.00547	CcSEcCtD
Enzalutamide—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.000586	0.00545	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.000584	0.00543	CcSEcCtD
Enzalutamide—CYP3A5—renal system—uterine cancer	0.000574	0.0193	CbGeAlD
Enzalutamide—AR—female gonad—uterine cancer	0.000573	0.0192	CbGeAlD
Enzalutamide—CYP2B6—renal system—uterine cancer	0.00057	0.0191	CbGeAlD
Enzalutamide—AR—vagina—uterine cancer	0.000569	0.0191	CbGeAlD
Enzalutamide—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000567	0.00527	CcSEcCtD
Enzalutamide—Insomnia—Progesterone—uterine cancer	0.000562	0.00524	CcSEcCtD
Enzalutamide—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00056	0.00521	CcSEcCtD
Enzalutamide—Paraesthesia—Progesterone—uterine cancer	0.000558	0.0052	CcSEcCtD
Enzalutamide—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000553	0.00514	CcSEcCtD
Enzalutamide—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000552	0.00514	CcSEcCtD
Enzalutamide—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000547	0.0051	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Progesterone—uterine cancer	0.000537	0.005	CcSEcCtD
Enzalutamide—Fatigue—Progesterone—uterine cancer	0.000536	0.00499	CcSEcCtD
Enzalutamide—CYP2C19—vagina—uterine cancer	0.000528	0.0177	CbGeAlD
Enzalutamide—Neutropenia—Etoposide—uterine cancer	0.000523	0.00487	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000513	0.00478	CcSEcCtD
Enzalutamide—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00051	0.00474	CcSEcCtD
Enzalutamide—CYP2C8—female reproductive system—uterine cancer	0.000509	0.0171	CbGeAlD
Enzalutamide—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000506	0.00471	CcSEcCtD
Enzalutamide—Musculoskeletal pain—Epirubicin—uterine cancer	0.000506	0.00471	CcSEcCtD
Enzalutamide—Pneumonia—Etoposide—uterine cancer	0.000502	0.00467	CcSEcCtD
Enzalutamide—Infestation—Etoposide—uterine cancer	0.000499	0.00464	CcSEcCtD
Enzalutamide—Infestation NOS—Etoposide—uterine cancer	0.000499	0.00464	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000486	0.00453	CcSEcCtD
Enzalutamide—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000486	0.00452	CcSEcCtD
Enzalutamide—Leukopenia—Dactinomycin—uterine cancer	0.000482	0.00449	CcSEcCtD
Enzalutamide—Musculoskeletal pain—Doxorubicin—uterine cancer	0.000468	0.00436	CcSEcCtD
Enzalutamide—CYP2C8—vagina—uterine cancer	0.00046	0.0155	CbGeAlD
Enzalutamide—CYP2B6—female reproductive system—uterine cancer	0.000457	0.0153	CbGeAlD
Enzalutamide—CYP2C9—female reproductive system—uterine cancer	0.000452	0.0152	CbGeAlD
Enzalutamide—Asthenia—Progesterone—uterine cancer	0.000446	0.00415	CcSEcCtD
Enzalutamide—Hypoaesthesia—Etoposide—uterine cancer	0.000446	0.00415	CcSEcCtD
Enzalutamide—Urinary tract disorder—Etoposide—uterine cancer	0.000442	0.00412	CcSEcCtD
Enzalutamide—Pruritus—Progesterone—uterine cancer	0.00044	0.0041	CcSEcCtD
Enzalutamide—Urethral disorder—Etoposide—uterine cancer	0.000439	0.00409	CcSEcCtD
Enzalutamide—Infection—Dactinomycin—uterine cancer	0.000437	0.00406	CcSEcCtD
Enzalutamide—Sepsis—Epirubicin—uterine cancer	0.000434	0.00404	CcSEcCtD
Enzalutamide—CYP3A4—renal system—uterine cancer	0.000431	0.0145	CbGeAlD
Enzalutamide—Thrombocytopenia—Dactinomycin—uterine cancer	0.00043	0.00401	CcSEcCtD
Enzalutamide—Diarrhoea—Progesterone—uterine cancer	0.000425	0.00396	CcSEcCtD
Enzalutamide—ALB—lymph node—uterine cancer	0.000424	0.0142	CbGeAlD
Enzalutamide—CYP2D6—renal system—uterine cancer	0.000424	0.0142	CbGeAlD
Enzalutamide—ABCB1—myometrium—uterine cancer	0.000419	0.0141	CbGeAlD
Enzalutamide—CYP3A5—female gonad—uterine cancer	0.000418	0.014	CbGeAlD
Enzalutamide—CYP3A5—vagina—uterine cancer	0.000416	0.014	CbGeAlD
Enzalutamide—CYP2B6—vagina—uterine cancer	0.000413	0.0139	CbGeAlD
Enzalutamide—Dizziness—Progesterone—uterine cancer	0.000411	0.00383	CcSEcCtD
Enzalutamide—Angiopathy—Etoposide—uterine cancer	0.000406	0.00378	CcSEcCtD
Enzalutamide—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000404	0.00376	CcSEcCtD
Enzalutamide—Sepsis—Doxorubicin—uterine cancer	0.000401	0.00374	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.0004	0.00373	CcSEcCtD
Enzalutamide—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000399	0.00371	CcSEcCtD
Enzalutamide—Headache—Progesterone—uterine cancer	0.00039	0.00363	CcSEcCtD
Enzalutamide—Hot flush—Epirubicin—uterine cancer	0.000388	0.00361	CcSEcCtD
Enzalutamide—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000386	0.00359	CcSEcCtD
Enzalutamide—Menopausal symptoms—Epirubicin—uterine cancer	0.000384	0.00358	CcSEcCtD
Enzalutamide—Fatigue—Dactinomycin—uterine cancer	0.000379	0.00353	CcSEcCtD
Enzalutamide—Back pain—Etoposide—uterine cancer	0.000377	0.00351	CcSEcCtD
Enzalutamide—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000373	0.00347	CcSEcCtD
Enzalutamide—AR—lymph node—uterine cancer	0.000368	0.0124	CbGeAlD
Enzalutamide—Hot flush—Doxorubicin—uterine cancer	0.000359	0.00334	CcSEcCtD
Enzalutamide—Menopausal symptoms—Doxorubicin—uterine cancer	0.000356	0.00331	CcSEcCtD
Enzalutamide—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000353	0.00329	CcSEcCtD
Enzalutamide—Vertigo—Etoposide—uterine cancer	0.00035	0.00326	CcSEcCtD
Enzalutamide—Leukopenia—Etoposide—uterine cancer	0.000349	0.00325	CcSEcCtD
Enzalutamide—CYP3A4—female reproductive system—uterine cancer	0.000345	0.0116	CbGeAlD
Enzalutamide—CYP2D6—female reproductive system—uterine cancer	0.000339	0.0114	CbGeAlD
Enzalutamide—Convulsion—Etoposide—uterine cancer	0.000338	0.00314	CcSEcCtD
Enzalutamide—Hypertension—Etoposide—uterine cancer	0.000337	0.00313	CcSEcCtD
Enzalutamide—Dry skin—Epirubicin—uterine cancer	0.000333	0.0031	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00033	0.00307	CcSEcCtD
Enzalutamide—ABCB1—epithelium—uterine cancer	0.000329	0.011	CbGeAlD
Enzalutamide—ABCB1—uterine cervix—uterine cancer	0.000326	0.0109	CbGeAlD
Enzalutamide—Nasopharyngitis—Epirubicin—uterine cancer	0.000324	0.00302	CcSEcCtD
Enzalutamide—Muscular weakness—Epirubicin—uterine cancer	0.00032	0.00298	CcSEcCtD
Enzalutamide—Infection—Etoposide—uterine cancer	0.000316	0.00294	CcSEcCtD
Enzalutamide—Asthenia—Dactinomycin—uterine cancer	0.000315	0.00294	CcSEcCtD
Enzalutamide—Thrombocytopenia—Etoposide—uterine cancer	0.000311	0.0029	CcSEcCtD
Enzalutamide—ABCB1—decidua—uterine cancer	0.00031	0.0104	CbGeAlD
Enzalutamide—Skin disorder—Etoposide—uterine cancer	0.000309	0.00288	CcSEcCtD
Enzalutamide—CYP2D6—female gonad—uterine cancer	0.000309	0.0104	CbGeAlD
Enzalutamide—Dry skin—Doxorubicin—uterine cancer	0.000308	0.00286	CcSEcCtD
Enzalutamide—ABCB1—renal system—uterine cancer	0.000305	0.0102	CbGeAlD
Enzalutamide—Bronchitis—Epirubicin—uterine cancer	0.000302	0.00281	CcSEcCtD
Enzalutamide—Diarrhoea—Dactinomycin—uterine cancer	0.000301	0.0028	CcSEcCtD
Enzalutamide—Nasopharyngitis—Doxorubicin—uterine cancer	0.0003	0.00279	CcSEcCtD
Enzalutamide—Muscular weakness—Doxorubicin—uterine cancer	0.000296	0.00276	CcSEcCtD
Enzalutamide—ABCB1—endometrium—uterine cancer	0.000295	0.00989	CbGeAlD
Enzalutamide—Neutropenia—Epirubicin—uterine cancer	0.000293	0.00273	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000291	0.00271	CcSEcCtD
Enzalutamide—Pollakiuria—Epirubicin—uterine cancer	0.00029	0.0027	CcSEcCtD
Enzalutamide—Paraesthesia—Etoposide—uterine cancer	0.000286	0.00266	CcSEcCtD
Enzalutamide—ABCB1—mammalian vulva—uterine cancer	0.000285	0.00957	CbGeAlD
Enzalutamide—Pneumonia—Epirubicin—uterine cancer	0.000281	0.00262	CcSEcCtD
Enzalutamide—Infestation—Epirubicin—uterine cancer	0.00028	0.0026	CcSEcCtD
Enzalutamide—Infestation NOS—Epirubicin—uterine cancer	0.00028	0.0026	CcSEcCtD
Enzalutamide—Bronchitis—Doxorubicin—uterine cancer	0.000279	0.0026	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Etoposide—uterine cancer	0.000275	0.00256	CcSEcCtD
Enzalutamide—Fatigue—Etoposide—uterine cancer	0.000274	0.00255	CcSEcCtD
Enzalutamide—ABCB1—uterus—uterine cancer	0.000272	0.00912	CbGeAlD
Enzalutamide—Neutropenia—Doxorubicin—uterine cancer	0.000271	0.00253	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.00027	0.00251	CcSEcCtD
Enzalutamide—Pollakiuria—Doxorubicin—uterine cancer	0.000268	0.0025	CcSEcCtD
Enzalutamide—Haematuria—Epirubicin—uterine cancer	0.000267	0.00248	CcSEcCtD
Enzalutamide—Epistaxis—Epirubicin—uterine cancer	0.000264	0.00245	CcSEcCtD
Enzalutamide—Sinusitis—Epirubicin—uterine cancer	0.000262	0.00244	CcSEcCtD
Enzalutamide—Pneumonia—Doxorubicin—uterine cancer	0.00026	0.00242	CcSEcCtD
Enzalutamide—Infestation NOS—Doxorubicin—uterine cancer	0.000259	0.00241	CcSEcCtD
Enzalutamide—Infestation—Doxorubicin—uterine cancer	0.000259	0.00241	CcSEcCtD
Enzalutamide—Rhinitis—Epirubicin—uterine cancer	0.000252	0.00234	CcSEcCtD
Enzalutamide—Hypoaesthesia—Epirubicin—uterine cancer	0.00025	0.00232	CcSEcCtD
Enzalutamide—Pharyngitis—Epirubicin—uterine cancer	0.000249	0.00232	CcSEcCtD
Enzalutamide—Urinary tract disorder—Epirubicin—uterine cancer	0.000248	0.00231	CcSEcCtD
Enzalutamide—Oedema peripheral—Epirubicin—uterine cancer	0.000247	0.0023	CcSEcCtD
Enzalutamide—Haematuria—Doxorubicin—uterine cancer	0.000247	0.0023	CcSEcCtD
Enzalutamide—Connective tissue disorder—Epirubicin—uterine cancer	0.000247	0.0023	CcSEcCtD
Enzalutamide—Urethral disorder—Epirubicin—uterine cancer	0.000246	0.00229	CcSEcCtD
Enzalutamide—ABCB1—female reproductive system—uterine cancer	0.000244	0.0082	CbGeAlD
Enzalutamide—Epistaxis—Doxorubicin—uterine cancer	0.000244	0.00227	CcSEcCtD
Enzalutamide—Sinusitis—Doxorubicin—uterine cancer	0.000243	0.00226	CcSEcCtD
Enzalutamide—Rhinitis—Doxorubicin—uterine cancer	0.000233	0.00217	CcSEcCtD
Enzalutamide—Hypoaesthesia—Doxorubicin—uterine cancer	0.000231	0.00215	CcSEcCtD
Enzalutamide—Pharyngitis—Doxorubicin—uterine cancer	0.00023	0.00215	CcSEcCtD
Enzalutamide—Urinary tract disorder—Doxorubicin—uterine cancer	0.000229	0.00213	CcSEcCtD
Enzalutamide—Oedema peripheral—Doxorubicin—uterine cancer	0.000229	0.00213	CcSEcCtD
Enzalutamide—Asthenia—Etoposide—uterine cancer	0.000228	0.00212	CcSEcCtD
Enzalutamide—Connective tissue disorder—Doxorubicin—uterine cancer	0.000228	0.00212	CcSEcCtD
Enzalutamide—Angiopathy—Epirubicin—uterine cancer	0.000228	0.00212	CcSEcCtD
Enzalutamide—Urethral disorder—Doxorubicin—uterine cancer	0.000228	0.00212	CcSEcCtD
Enzalutamide—Pruritus—Etoposide—uterine cancer	0.000225	0.0021	CcSEcCtD
Enzalutamide—ABCB1—female gonad—uterine cancer	0.000222	0.00746	CbGeAlD
Enzalutamide—ABCB1—vagina—uterine cancer	0.000221	0.00741	CbGeAlD
Enzalutamide—Mental disorder—Epirubicin—uterine cancer	0.00022	0.00205	CcSEcCtD
Enzalutamide—Diarrhoea—Etoposide—uterine cancer	0.000218	0.00203	CcSEcCtD
Enzalutamide—Back pain—Epirubicin—uterine cancer	0.000211	0.00197	CcSEcCtD
Enzalutamide—Angiopathy—Doxorubicin—uterine cancer	0.000211	0.00196	CcSEcCtD
Enzalutamide—Dizziness—Etoposide—uterine cancer	0.00021	0.00196	CcSEcCtD
Enzalutamide—Mental disorder—Doxorubicin—uterine cancer	0.000203	0.00189	CcSEcCtD
Enzalutamide—Headache—Etoposide—uterine cancer	0.000199	0.00186	CcSEcCtD
Enzalutamide—Vertigo—Epirubicin—uterine cancer	0.000196	0.00183	CcSEcCtD
Enzalutamide—Leukopenia—Epirubicin—uterine cancer	0.000196	0.00182	CcSEcCtD
Enzalutamide—Back pain—Doxorubicin—uterine cancer	0.000196	0.00182	CcSEcCtD
Enzalutamide—Convulsion—Epirubicin—uterine cancer	0.000189	0.00176	CcSEcCtD
Enzalutamide—Hypertension—Epirubicin—uterine cancer	0.000189	0.00176	CcSEcCtD
Enzalutamide—Arthralgia—Epirubicin—uterine cancer	0.000186	0.00173	CcSEcCtD
Enzalutamide—Anxiety—Epirubicin—uterine cancer	0.000185	0.00173	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000185	0.00172	CcSEcCtD
Enzalutamide—Vertigo—Doxorubicin—uterine cancer	0.000182	0.00169	CcSEcCtD
Enzalutamide—Leukopenia—Doxorubicin—uterine cancer	0.000181	0.00168	CcSEcCtD
Enzalutamide—Infection—Epirubicin—uterine cancer	0.000177	0.00165	CcSEcCtD
Enzalutamide—Convulsion—Doxorubicin—uterine cancer	0.000175	0.00163	CcSEcCtD
Enzalutamide—Nervous system disorder—Epirubicin—uterine cancer	0.000175	0.00163	CcSEcCtD
Enzalutamide—Thrombocytopenia—Epirubicin—uterine cancer	0.000175	0.00163	CcSEcCtD
Enzalutamide—Hypertension—Doxorubicin—uterine cancer	0.000175	0.00162	CcSEcCtD
Enzalutamide—Skin disorder—Epirubicin—uterine cancer	0.000173	0.00161	CcSEcCtD
Enzalutamide—Arthralgia—Doxorubicin—uterine cancer	0.000172	0.0016	CcSEcCtD
Enzalutamide—Anxiety—Doxorubicin—uterine cancer	0.000172	0.0016	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000171	0.00159	CcSEcCtD
Enzalutamide—Infection—Doxorubicin—uterine cancer	0.000164	0.00153	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000162	0.00151	CcSEcCtD
Enzalutamide—Nervous system disorder—Doxorubicin—uterine cancer	0.000162	0.00151	CcSEcCtD
Enzalutamide—Thrombocytopenia—Doxorubicin—uterine cancer	0.000162	0.0015	CcSEcCtD
Enzalutamide—Insomnia—Epirubicin—uterine cancer	0.000161	0.0015	CcSEcCtD
Enzalutamide—Skin disorder—Doxorubicin—uterine cancer	0.00016	0.00149	CcSEcCtD
Enzalutamide—Paraesthesia—Epirubicin—uterine cancer	0.00016	0.00149	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000154	0.00143	CcSEcCtD
Enzalutamide—Fatigue—Epirubicin—uterine cancer	0.000154	0.00143	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.00015	0.0014	CcSEcCtD
Enzalutamide—Insomnia—Doxorubicin—uterine cancer	0.000149	0.00139	CcSEcCtD
Enzalutamide—Paraesthesia—Doxorubicin—uterine cancer	0.000148	0.00138	CcSEcCtD
Enzalutamide—ABCB1—lymph node—uterine cancer	0.000143	0.00479	CbGeAlD
Enzalutamide—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000142	0.00133	CcSEcCtD
Enzalutamide—Fatigue—Doxorubicin—uterine cancer	0.000142	0.00132	CcSEcCtD
Enzalutamide—Asthenia—Epirubicin—uterine cancer	0.000128	0.00119	CcSEcCtD
Enzalutamide—Pruritus—Epirubicin—uterine cancer	0.000126	0.00117	CcSEcCtD
Enzalutamide—Diarrhoea—Epirubicin—uterine cancer	0.000122	0.00114	CcSEcCtD
Enzalutamide—Asthenia—Doxorubicin—uterine cancer	0.000118	0.0011	CcSEcCtD
Enzalutamide—Dizziness—Epirubicin—uterine cancer	0.000118	0.0011	CcSEcCtD
Enzalutamide—Pruritus—Doxorubicin—uterine cancer	0.000117	0.00109	CcSEcCtD
Enzalutamide—Diarrhoea—Doxorubicin—uterine cancer	0.000113	0.00105	CcSEcCtD
Enzalutamide—Headache—Epirubicin—uterine cancer	0.000112	0.00104	CcSEcCtD
Enzalutamide—Dizziness—Doxorubicin—uterine cancer	0.000109	0.00102	CcSEcCtD
Enzalutamide—Headache—Doxorubicin—uterine cancer	0.000103	0.000962	CcSEcCtD
Enzalutamide—ALB—Transmembrane transport of small molecules—ABCC9—uterine cancer	3.95e-05	0.00161	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	3.93e-05	0.00161	CbGpPWpGaD
Enzalutamide—CYP2D6—Biological oxidations—CYP19A1—uterine cancer	3.93e-05	0.00161	CbGpPWpGaD
Enzalutamide—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	3.89e-05	0.00159	CbGpPWpGaD
Enzalutamide—CYP2D6—Metapathway biotransformation—CYP19A1—uterine cancer	3.87e-05	0.00158	CbGpPWpGaD
Enzalutamide—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	3.84e-05	0.00157	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	3.83e-05	0.00157	CbGpPWpGaD
Enzalutamide—AR—Generic Transcription Pathway—SMAD3—uterine cancer	3.82e-05	0.00156	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	3.75e-05	0.00153	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	3.72e-05	0.00152	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	3.72e-05	0.00152	CbGpPWpGaD
Enzalutamide—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	3.71e-05	0.00152	CbGpPWpGaD
Enzalutamide—AR—Integrated Breast Cancer Pathway—KRAS—uterine cancer	3.64e-05	0.00149	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—CXCL8—uterine cancer	3.61e-05	0.00148	CbGpPWpGaD
Enzalutamide—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	3.57e-05	0.00146	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	3.55e-05	0.00145	CbGpPWpGaD
Enzalutamide—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	3.49e-05	0.00143	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	3.46e-05	0.00141	CbGpPWpGaD
Enzalutamide—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	3.44e-05	0.00141	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	3.44e-05	0.0014	CbGpPWpGaD
Enzalutamide—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	3.41e-05	0.00139	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	3.4e-05	0.00139	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	3.4e-05	0.00139	CbGpPWpGaD
Enzalutamide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	3.39e-05	0.00138	CbGpPWpGaD
Enzalutamide—ALB—Platelet degranulation—VEGFA—uterine cancer	3.31e-05	0.00135	CbGpPWpGaD
Enzalutamide—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	3.25e-05	0.00133	CbGpPWpGaD
Enzalutamide—AR—Integrated Breast Cancer Pathway—TP53—uterine cancer	3.24e-05	0.00132	CbGpPWpGaD
Enzalutamide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—uterine cancer	3.16e-05	0.00129	CbGpPWpGaD
Enzalutamide—AR—Generic Transcription Pathway—ESR1—uterine cancer	3.12e-05	0.00128	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.06e-05	0.00125	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.05e-05	0.00125	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—NDUFB11—uterine cancer	3.04e-05	0.00124	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—SRD5A2—uterine cancer	3.04e-05	0.00124	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	3.02e-05	0.00123	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—SRD5A2—uterine cancer	2.97e-05	0.00121	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—NDUFB11—uterine cancer	2.97e-05	0.00121	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—VEGFA—uterine cancer	2.93e-05	0.0012	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—TP53—uterine cancer	2.92e-05	0.00119	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—PGR—uterine cancer	2.81e-05	0.00115	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	2.77e-05	0.00113	CbGpPWpGaD
Enzalutamide—AR—Integrated Breast Cancer Pathway—AKT1—uterine cancer	2.73e-05	0.00112	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.73e-05	0.00112	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	2.68e-05	0.0011	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—EZH2—uterine cancer	2.67e-05	0.00109	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—SRD5A2—uterine cancer	2.57e-05	0.00105	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—NDUFB11—uterine cancer	2.57e-05	0.00105	CbGpPWpGaD
Enzalutamide—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	2.57e-05	0.00105	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—IRF1—uterine cancer	2.56e-05	0.00105	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	2.56e-05	0.00105	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—NDUFB11—uterine cancer	2.56e-05	0.00105	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—SRD5A2—uterine cancer	2.56e-05	0.00105	CbGpPWpGaD
Enzalutamide—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	2.53e-05	0.00104	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.5e-05	0.00102	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.49e-05	0.00102	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.48e-05	0.00102	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—ESR2—uterine cancer	2.48e-05	0.00101	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.36e-05	0.000964	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.34e-05	0.000959	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—NDUFB11—uterine cancer	2.29e-05	0.000938	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—SRD5A2—uterine cancer	2.29e-05	0.000938	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	2.27e-05	0.000926	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—SRD5A2—uterine cancer	2.24e-05	0.000916	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—NDUFB11—uterine cancer	2.24e-05	0.000916	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.23e-05	0.000911	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—STAR—uterine cancer	2.19e-05	0.000898	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—AKR1B1—uterine cancer	2.19e-05	0.000898	CbGpPWpGaD
Enzalutamide—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	2.16e-05	0.000883	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—AKR1B1—uterine cancer	2.15e-05	0.000877	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—STAR—uterine cancer	2.15e-05	0.000877	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—NDUFB11—uterine cancer	2.11e-05	0.000863	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—SRD5A2—uterine cancer	2.11e-05	0.000863	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.1e-05	0.000861	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—SRD5A2—uterine cancer	2.09e-05	0.000855	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—NDUFB11—uterine cancer	2.09e-05	0.000855	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.03e-05	0.000831	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—CDKN2B—uterine cancer	2.02e-05	0.000824	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.92e-05	0.000785	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.88e-05	0.000768	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—AKR1B1—uterine cancer	1.86e-05	0.00076	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—STAR—uterine cancer	1.86e-05	0.00076	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—AKR1B1—uterine cancer	1.85e-05	0.000756	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—STAR—uterine cancer	1.85e-05	0.000756	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—SMAD3—uterine cancer	1.84e-05	0.000753	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.84e-05	0.000751	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.83e-05	0.000747	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.74e-05	0.000712	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—POLD1—uterine cancer	1.72e-05	0.000704	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—POLD1—uterine cancer	1.68e-05	0.000688	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—STAR—uterine cancer	1.66e-05	0.000678	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—AKR1B1—uterine cancer	1.66e-05	0.000678	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.64e-05	0.000672	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.64e-05	0.00067	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—AKR1B1—uterine cancer	1.62e-05	0.000662	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—STAR—uterine cancer	1.62e-05	0.000662	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—AKR1C1—uterine cancer	1.61e-05	0.000659	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.6e-05	0.000655	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—AKR1C1—uterine cancer	1.57e-05	0.000644	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.53e-05	0.000625	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—AKR1B1—uterine cancer	1.53e-05	0.000624	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—STAR—uterine cancer	1.53e-05	0.000624	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—STAR—uterine cancer	1.51e-05	0.000618	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—AKR1B1—uterine cancer	1.51e-05	0.000618	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—ESR1—uterine cancer	1.5e-05	0.000614	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.49e-05	0.000611	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	1.47e-05	0.000601	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—POLD1—uterine cancer	1.46e-05	0.000596	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—POLD1—uterine cancer	1.45e-05	0.000593	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.45e-05	0.000592	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—RRM2—uterine cancer	1.44e-05	0.000587	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—RRM2—uterine cancer	1.4e-05	0.000574	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—DCN—uterine cancer	1.39e-05	0.00057	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.38e-05	0.000564	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.38e-05	0.000564	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—AKR1C1—uterine cancer	1.36e-05	0.000558	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—DCN—uterine cancer	1.36e-05	0.000557	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—AKR1C1—uterine cancer	1.36e-05	0.000555	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CYP11A1—uterine cancer	1.31e-05	0.000537	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—POLD1—uterine cancer	1.3e-05	0.000532	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CYP11A1—uterine cancer	1.28e-05	0.000525	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—POLD1—uterine cancer	1.27e-05	0.00052	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—AKR1C3—uterine cancer	1.24e-05	0.000507	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.23e-05	0.000503	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—AKR1C1—uterine cancer	1.22e-05	0.000498	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—RRM2—uterine cancer	1.22e-05	0.000497	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—AKR1C3—uterine cancer	1.21e-05	0.000496	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—RRM2—uterine cancer	1.21e-05	0.000494	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—POLD1—uterine cancer	1.2e-05	0.00049	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—AKR1C1—uterine cancer	1.19e-05	0.000486	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—POLD1—uterine cancer	1.19e-05	0.000485	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—DCN—uterine cancer	1.18e-05	0.000483	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—DCN—uterine cancer	1.17e-05	0.00048	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	1.15e-05	0.000469	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.13e-05	0.000462	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—AKR1C1—uterine cancer	1.12e-05	0.000458	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CYP11A1—uterine cancer	1.11e-05	0.000455	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—AKR1C1—uterine cancer	1.11e-05	0.000454	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CYP11A1—uterine cancer	1.11e-05	0.000452	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.09e-05	0.000447	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—RRM2—uterine cancer	1.09e-05	0.000444	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—RRM2—uterine cancer	1.06e-05	0.000433	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—DCN—uterine cancer	1.05e-05	0.000431	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—AKR1C3—uterine cancer	1.05e-05	0.000429	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—AKR1C3—uterine cancer	1.04e-05	0.000427	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—DCN—uterine cancer	1.03e-05	0.00042	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—RRM2—uterine cancer	9.98e-06	0.000408	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—AKR1B1—uterine cancer	9.97e-06	0.000408	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—STAR—uterine cancer	9.97e-06	0.000408	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CYP11A1—uterine cancer	9.92e-06	0.000406	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—RRM2—uterine cancer	9.89e-06	0.000405	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—DCN—uterine cancer	9.69e-06	0.000396	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CYP11A1—uterine cancer	9.69e-06	0.000396	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CYP19A1—uterine cancer	9.66e-06	0.000395	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—STK11—uterine cancer	9.66e-06	0.000395	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—DCN—uterine cancer	9.61e-06	0.000393	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—STK11—uterine cancer	9.44e-06	0.000386	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CYP19A1—uterine cancer	9.44e-06	0.000386	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	9.38e-06	0.000383	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—AKR1C3—uterine cancer	9.37e-06	0.000383	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	9.23e-06	0.000378	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—AKR1C3—uterine cancer	9.15e-06	0.000374	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYP11A1—uterine cancer	9.13e-06	0.000373	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYP11A1—uterine cancer	9.05e-06	0.00037	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—AKR1C3—uterine cancer	8.62e-06	0.000353	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—AKR1C3—uterine cancer	8.55e-06	0.000349	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—STK11—uterine cancer	8.18e-06	0.000335	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CYP19A1—uterine cancer	8.18e-06	0.000335	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—STK11—uterine cancer	8.13e-06	0.000333	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CYP19A1—uterine cancer	8.13e-06	0.000333	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—EP300—uterine cancer	8e-06	0.000327	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—POLD1—uterine cancer	7.83e-06	0.00032	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.68e-06	0.000314	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.64e-06	0.000312	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—VEGFA—uterine cancer	7.58e-06	0.00031	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—NRAS—uterine cancer	7.48e-06	0.000306	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.32e-06	0.000299	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—AKR1C1—uterine cancer	7.32e-06	0.000299	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CYP19A1—uterine cancer	7.3e-06	0.000299	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—STK11—uterine cancer	7.3e-06	0.000299	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.28e-06	0.000298	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—MTHFR—uterine cancer	7.26e-06	0.000297	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—STK11—uterine cancer	7.13e-06	0.000291	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CYP19A1—uterine cancer	7.13e-06	0.000291	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—MTHFR—uterine cancer	7.1e-06	0.00029	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.85e-06	0.00028	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—STK11—uterine cancer	6.72e-06	0.000275	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYP19A1—uterine cancer	6.72e-06	0.000275	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYP19A1—uterine cancer	6.66e-06	0.000272	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—STK11—uterine cancer	6.66e-06	0.000272	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.54e-06	0.000267	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—RRM2—uterine cancer	6.53e-06	0.000267	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—KRAS—uterine cancer	6.44e-06	0.000263	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—DCN—uterine cancer	6.33e-06	0.000259	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.25e-06	0.000256	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—MTHFR—uterine cancer	6.15e-06	0.000251	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—MTHFR—uterine cancer	6.11e-06	0.00025	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP11A1—uterine cancer	5.97e-06	0.000244	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.96e-06	0.000244	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—PIK3CA—uterine cancer	5.92e-06	0.000242	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—TP53—uterine cancer	5.72e-06	0.000234	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—AKR1C3—uterine cancer	5.64e-06	0.00023	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—MTHFR—uterine cancer	5.49e-06	0.000224	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—HRAS—uterine cancer	5.47e-06	0.000224	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—AKT1—uterine cancer	5.42e-06	0.000222	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.42e-06	0.000222	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.39e-06	0.00022	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—MTHFR—uterine cancer	5.36e-06	0.000219	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—MTHFR—uterine cancer	5.05e-06	0.000206	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—MTHFR—uterine cancer	5e-06	0.000205	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.84e-06	0.000198	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—AKT1—uterine cancer	4.83e-06	0.000198	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.41e-06	0.00018	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP19A1—uterine cancer	4.39e-06	0.00018	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—STK11—uterine cancer	4.39e-06	0.00018	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PTEN—uterine cancer	4.04e-06	0.000165	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PTEN—uterine cancer	3.95e-06	0.000161	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—EP300—uterine cancer	3.85e-06	0.000158	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—EP300—uterine cancer	3.77e-06	0.000154	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PTEN—uterine cancer	3.42e-06	0.00014	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PTEN—uterine cancer	3.4e-06	0.000139	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—MTHFR—uterine cancer	3.3e-06	0.000135	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—EP300—uterine cancer	3.26e-06	0.000133	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—EP300—uterine cancer	3.24e-06	0.000133	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PTEN—uterine cancer	3.05e-06	0.000125	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PTEN—uterine cancer	2.98e-06	0.000122	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—EP300—uterine cancer	2.91e-06	0.000119	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PIK3CA—uterine cancer	2.85e-06	0.000117	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—EP300—uterine cancer	2.84e-06	0.000116	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PTEN—uterine cancer	2.81e-06	0.000115	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PIK3CA—uterine cancer	2.79e-06	0.000114	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PTEN—uterine cancer	2.78e-06	0.000114	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—EP300—uterine cancer	2.68e-06	0.000109	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—EP300—uterine cancer	2.65e-06	0.000109	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PIK3CA—uterine cancer	2.41e-06	9.87e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PIK3CA—uterine cancer	2.4e-06	9.81e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—AKT1—uterine cancer	2.33e-06	9.52e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—AKT1—uterine cancer	2.28e-06	9.31e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PIK3CA—uterine cancer	2.15e-06	8.81e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PIK3CA—uterine cancer	2.1e-06	8.6e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PIK3CA—uterine cancer	1.98e-06	8.1e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—AKT1—uterine cancer	1.97e-06	8.06e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PIK3CA—uterine cancer	1.96e-06	8.03e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—AKT1—uterine cancer	1.96e-06	8.01e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PTEN—uterine cancer	1.84e-06	7.51e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—AKT1—uterine cancer	1.76e-06	7.19e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—EP300—uterine cancer	1.75e-06	7.16e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—AKT1—uterine cancer	1.72e-06	7.02e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—AKT1—uterine cancer	1.62e-06	6.62e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—AKT1—uterine cancer	1.6e-06	6.56e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.29e-06	5.3e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—AKT1—uterine cancer	1.06e-06	4.33e-05	CbGpPWpGaD
